Journal of Labor and Childbirth

Cancer Immunotherapy Scientific Journals

 Cancer may be a global issue and one among the leading causes of death within the developed world. per annum , there are some 14 million new cases of cancer diagnosed worldwide with 350 000 of said cases occurring within the UK1 . Approximately half these cases end in death to the patient before reaching 10 years post-diagnosis1 . Still, cancer survival has almost doubled within the last 40 years1 as a results of research efforts in prevention, early diagnosis, and treatment options. The system is documented for shielding us against numerous infections but is now known to be important in detecting and destroying cancers. Early work, from over a century ago, suggested that activation of the system might help to combat cancer; we now know with certainty that the system plays a crucial role in detecting and killing cancer cells. However, as cancers develop they become immune to the system – cancer is claimed to evade immunity. Bypassing this evasion has become a main focus of research into novel cancer therapies. Traditional cancer treatments include chemotherapy, radiotherapy, and surgery. There are significant advancements in cancer management and treatment, which have reduced cancer morbidity and mortality substantially. However, these are commonly related to unpleasant side-effects, like nausea, fatigue, and hair loss. New research is consistently trying to find novel and more refined ways of treating or managing cancer. Cancer immunotherapy is meant to reactivate the body’s immune reaction to the cancer and is showing exciting promise, with clear benefit now demonstrated in some cancers like melanoma, lung, kidney, head and neck and Hodgkin’s lymphoma.  

High Impact List of Articles

Relevant Topics in Material Science